Advances in Treatment of Previously Treated Ph+ Chronic Myeloid Leukemia

Experts come together to share their perspective on the paradigm of previously treated Ph+ chronic myeloid leukemia.

February 16th 2022

An overview of the general toxicities patients may experience while undergoing therapy for chronic myeloid leukemia.

February 23rd 2022

Daniel DeAngelo, MD, PhD, provides his perspective on improving CML care through dose adjustment or treatment discontinuation.

February 23rd 2022

Moshe Talpaz, MD, discusses best practices in monitoring patients with CML and applying multidisciplinary care.

March 2nd 2022

Closing out their discussion on the management of chronic myeloid leukemia, experts share practical advice and excitement for novel strategies.